API Supplier Diversification: Key Checks

When pharmaceutical companies diversify their active pharmaceutical ingredient (API) suppliers, they must check regulatory compliance, quality systems, technical capability, financial stability, supply chain resilience, and geographic risk—before signing any contract. This article outlines the essential due diligence steps, common pitfalls, and practical strategies for building a robust multi-supplier network.

Why Diversify API Suppliers?

Relying on a single API source is risky. A fire at one plant, a sudden regulatory shutdown, or a geopolitical crisis can halt production of a critical medicine. The 2018 recall of valsartan due to NDMA contamination, which originated from a single Chinese supplier, forced many companies to scramble for alternatives. Diversification reduces this vulnerability, improves negotiating leverage, and can lower costs over time. However, adding suppliers without proper vetting can create new risks—quality failures, supply delays, or regulatory non-compliance.

Regulatory and Compliance Checks

Every potential API supplier must meet the regulatory standards of the markets where the final drug will be sold. For the US, that means FDA registration and current Good Manufacturing Practice (cGMP) compliance. For the EU, it requires a Certificate of Suitability (CEP) or an Active Substance Master File (ASMF) reviewed by the European Medicines Agency. Check that the supplier’s facilities have passed recent inspections without critical findings. Ask for their Drug Master File (DMF) number and verify it is active. Also confirm that the supplier can provide the required documentation for each batch, including certificates of analysis, stability data, and impurity profiles.

Quality Systems and Technical Capability

A supplier may have the right paperwork but lack the technical expertise to consistently produce your API. Evaluate their quality management system—does it follow ICH Q10? Are their equipment and processes validated? Request a detailed technical package that includes the synthetic route, process controls, and in-process testing. Conduct an on-site audit if possible, focusing on cleanliness, equipment calibration, and staff training. Also assess their ability to scale production to meet your forecasted demand. A supplier that can only produce small batches may not be viable for commercial launches.

Financial Stability and Business Continuity

An API supplier that goes bankrupt mid-contract can cause months of delay. Review their financial statements, credit ratings, and payment history. Look for signs of distress—such as layoffs, asset sales, or lawsuits. Also evaluate their business continuity plans: Do they have backup power, redundant equipment, and alternative raw material sources? Ask about their own suppliers for starting materials and intermediates, as a disruption upstream can affect you. A financially healthy supplier with a resilient supply chain is a safer long-term partner.

Geopolitical and Logistics Risks

Geographic diversification is a key part of risk reduction. If all your suppliers are in the same region, a regional crisis—like a typhoon in China or a trade war—can still halt production. Consider suppliers in different countries or at least different regions. Evaluate logistics: shipping times, customs clearance, and the availability of cold chain if needed. Also assess the political stability and regulatory environment of the supplier’s country. For example, India and China dominate API manufacturing, but each has unique risks—India has regulatory scrutiny, China has trade tensions. A balanced portfolio might include one supplier in each, plus a domestic option.

How to Choose a Second Supplier

When selecting a backup or second supplier, follow a structured process:

• Define your requirements: API specification, batch size, packaging, and delivery schedule.
• Create a longlist of candidates from trade shows, industry directories, and regulatory databases.
• Send a Request for Information (RFI) to gauge interest and capability.
• Request samples and perform analytical testing to verify purity and impurity profiles.
• Conduct a technical audit and review their quality systems.
• Negotiate a contract that includes clear quality agreements, delivery penalties, and confidentiality clauses.
• Qualify the supplier through stability studies and regulatory filings (e.g., a new DMF or ASMF).

This process can take 6–18 months, so start early and maintain a rolling pipeline of potential suppliers.

Common Problems and Misconceptions

One common misconception is that a second supplier only needs to match the first supplier’s product. In reality, the API must meet your original specification, not just the other supplier’s spec. This requires re-validating the analytical methods and possibly adjusting your formulation. Another problem is underestimating the cost of qualification—stability studies, regulatory filings, and audits can cost hundreds of thousands of dollars. Also, companies often forget to update their supply agreement with the new supplier’s terms, leading to disputes later. Finally, do not assume that a supplier with a valid DMF is currently manufacturing the API—some DMFs are dormant, and the supplier may need to restart production.

Costs and Contractual Considerations

Diversifying suppliers does not necessarily double costs, but it does add expenses: qualification, validation, and potential higher unit prices from smaller suppliers. To manage this, consider a dual-supplier strategy where you allocate a percentage of volume to each (e.g., 70/30). This gives you leverage and ensures the backup supplier stays active. In contracts, include clauses for capacity guarantees, minimum order quantities, and force majeure. Also, agree on a quality agreement that defines responsibilities for testing, release, and recalls. Be aware of intellectual property risks—ensure your process is protected or that the supplier signs non-disclosure agreements.

Frequently Asked Questions

How many API suppliers should a company have?

There is no universal number, but a common best practice is to have at least two suppliers for critical APIs, and three if the API is high-volume or high-risk. The exact number depends on the drug’s therapeutic importance, the supply chain’s complexity, and the cost of qualification.

Can a small biotech afford to diversify suppliers?

Small companies often struggle with the upfront costs. A practical approach is to start with one supplier, but develop a second one early, even if you only buy small quantities. This keeps the relationship warm and reduces the lead time if you need to scale up.

What is the difference between a DMF and a CEP?

A Drug Master File (DMF) is a confidential document submitted to the FDA that contains details of the API manufacturing process. A Certificate of Suitability (CEP) is a certificate from the European Directorate for the Quality of Medicines (EDQM) confirming that the API complies with the European Pharmacopoeia. Both serve as reference documents for regulatory review.

How long does it take to qualify a new API supplier?

Typically 6 to 18 months, depending on the complexity of the API, the supplier’s readiness, and the need for stability studies. Regulatory filings can add more time, especially if you need to update your marketing authorization.

What are the red flags in an API supplier audit?

Look for incomplete batch records, unvalidated cleaning procedures, poor lab practices, and a lack of deviation investigations. Also, be wary of suppliers who are reluctant to share data or who have had recent regulatory warnings.

Is it better to have suppliers in the same country?

Not necessarily. Same-country suppliers reduce shipping time and regulatory complexity, but they do not protect against country-wide events like natural disasters or political instability. A mix of domestic and international suppliers often provides the best balance.

Related

• Keep Me Signed In: What It Means & How It Works
• Unlock Motorola Phone After Factory Reset
• Todo Backup Guide: Full Steps for Files, System, and Apps